About the Woolly Mammoth Revivalists
George Church, Ph.D. Founding Core Faculty Member Platform Lead, Synthetic Biology Wyss Institute Professor of Genetics Harvard Medical School Professor of Health Sciences and Technology Harvard and MIT George leads the Synthetic Biology Platform, where he oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bioenergy. Among his recent work at the Wyss is development of a technology for synthesizing whole genes, and potentially whole gene circuits, that is faster, more accurate, and significantly less expensive than current methods. George is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. In 1984, he developed the first direct genomic sequencing method, which resulted in the first commercial genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. George invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. His many innovations have been the basis for a number of companies including Joule Unlimited, Inc. (solar fuels); LS9, Inc. (bio-petroleum); and Knome (full human genome sequencing).
Bobby Dhadwar is a postdoctoral fellow in the George Church lab with a primary research focus on developing age-reversal and anti-aging technologies. He did a PHD in Canada at McMaster University, where he developed new gene therapy strategies for blood disorders.
Luhan Yang had her Ph.D training in human biology and translational medicine at Harvard. Currently, she is working at Dr. Church lab as a postdoc, further developing genome editing technology that she studied at her Ph. D. She is also a cofounder of a biotech startup EGenesis, aiming to create novel organisms for the benefit of human health.
Justin Quinn is a self-described ‘Molecular Ninja’. He currently works in the Molecular Biology department at Warp Drive Bio, a company co-founded by George Church— and using the state-of-the art techniques (Crispr) which we are intending to use for de-extinction genome editing.